全文获取类型
收费全文 | 518877篇 |
免费 | 33830篇 |
国内免费 | 610篇 |
专业分类
耳鼻咽喉 | 7215篇 |
儿科学 | 17161篇 |
妇产科学 | 13967篇 |
基础医学 | 85384篇 |
口腔科学 | 14831篇 |
临床医学 | 44784篇 |
内科学 | 93928篇 |
皮肤病学 | 12331篇 |
神经病学 | 36301篇 |
特种医学 | 18605篇 |
外国民族医学 | 63篇 |
外科学 | 78017篇 |
综合类 | 8922篇 |
一般理论 | 127篇 |
预防医学 | 39385篇 |
眼科学 | 12405篇 |
药学 | 40764篇 |
中国医学 | 979篇 |
肿瘤学 | 28148篇 |
出版年
2018年 | 4894篇 |
2015年 | 4550篇 |
2014年 | 6132篇 |
2013年 | 9633篇 |
2012年 | 13008篇 |
2011年 | 14406篇 |
2010年 | 8365篇 |
2009年 | 7835篇 |
2008年 | 13805篇 |
2007年 | 14855篇 |
2006年 | 15072篇 |
2005年 | 14484篇 |
2004年 | 14133篇 |
2003年 | 13439篇 |
2002年 | 13301篇 |
2001年 | 24061篇 |
2000年 | 25057篇 |
1999年 | 20476篇 |
1998年 | 5151篇 |
1997年 | 4428篇 |
1996年 | 4765篇 |
1995年 | 4595篇 |
1994年 | 4306篇 |
1993年 | 4125篇 |
1992年 | 15709篇 |
1991年 | 16310篇 |
1990年 | 16421篇 |
1989年 | 15792篇 |
1988年 | 14570篇 |
1987年 | 14413篇 |
1986年 | 13587篇 |
1985年 | 12975篇 |
1984年 | 9612篇 |
1983年 | 8236篇 |
1982年 | 4544篇 |
1981年 | 4216篇 |
1979年 | 9405篇 |
1978年 | 6837篇 |
1977年 | 5753篇 |
1976年 | 5578篇 |
1975年 | 6369篇 |
1974年 | 7622篇 |
1973年 | 7122篇 |
1972年 | 6949篇 |
1971年 | 6674篇 |
1970年 | 6167篇 |
1969年 | 5882篇 |
1968年 | 5557篇 |
1967年 | 5011篇 |
1966年 | 4449篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Dikshat Gopal Gupta PhD Neelam Varma MD Praveen Sharma MD Mihai I. Truica MD PhD Sarki A. Abdulkadir MD PhD Parmod Singh PhD Man Updesh Singh Sachdeva MD Shano Naseem MD Mohammad Rizwan Siddiqui PhD Parveen Bose MSc Jogeshwar Binota MSc Pankaj Malhotra MD Alka Khadwal MD Amita Trehan Subhash Varma MD 《Cancer》2023,129(21):3390-3404
2.
Birgit M. M. Wever Rianne van den Helder Annina P. van Splunter Mignon D. J. M. van Gent Jenneke C. Kasius Johannes W. Trum Harold R. Verhoeve Wilhelmina M. van Baal Alicia Hulbert Lisanne Verhoef Daniëlle A. M. Heideman Birgit I. Lissenberg-Witte Nienke E. van Trommel Renske D. M. Steenbergen Maaike C. G. Bleeker 《International journal of cancer. Journal international du cancer》2023,153(2):341-351
Endometrial cancer incidence is rising and current diagnostics often require invasive biopsy procedures. DNA methylation marker analysis of minimally- and non-invasive sample types could provide an easy-to-apply and patient-friendly alternative to determine cancer risk. Here, we compared the performance of DNA methylation markers to detect endometrial cancer in urine, cervicovaginal self-samples and clinician-taken cervical scrapes. Paired samples were collected from 103 patients diagnosed with stage I to IV endometrial cancer. Urine and self-samples were collected at home. All samples were tested for nine DNA methylation markers using quantitative methylation-specific PCR. Methylation levels measured in endometrial cancer patients were compared to unpaired samples of 317 healthy controls. Diagnostic performances were evaluated by univariable and multivariable logistic regression analysis, followed by leave-one-out cross-validation. Each methylation marker showed significantly higher methylation levels in all sample types of endometrial cancer patients compared to healthy controls (P < .01). Optimal three-marker combinations demonstrated excellent diagnostic performances with area under the receiver operating curve values of 0.95 (95% CI: 0.92-0.98), 0.94 (0.90-0.97) and 0.97 (0.96-0.99), for endometrial cancer detection in urine, self-samples and scrapes, respectively. Sensitivities ranged from 89% to 93% at specificities of 90% to 92%. Virtually equal performances were obtained after cross-validation and excellent diagnostic performances were maintained for stage I endometrial cancer detection. Our study shows the value of methylation analysis in patient-friendly sample types for endometrial cancer detection of all stages. This approach has great potential to screen patient populations at risk for endometrial cancer. 相似文献
3.
Bartlomiej Gielniewski Katarzyna Poleszak Adria-Jaume Roura Paulina Szadkowska Karol Jacek Sylwia K. Krol Rafal Guzik Paulina Wiechecka Marta Maleszewska Beata Kaza Andrzej Marchel Tomasz Czernicki Andrzej Koziarski Grzegorz Zielinski Andrzej Styk Maciej Kawecki Cezary Szczylik Ryszard Czepko Mariusz Banach Wojciech Kaspera Wojciech Szopa Mateusz Bujko Bartosz Czapski Miroslaw Zabek Ewa Iżycka-Świeszewska Wojciech Kloc Pawel Nauman Joanna Cieslewicz Wieslawa Grajkowska Natalia Morosini Houtan Noushmehr Bartosz Wojtas Bozena Kaminska 《International journal of cancer. Journal international du cancer》2023,153(5):1003-1015
4.
5.
6.
Thomas Fuchs-Buder Sorin J. Brull Malin Jonsson Fagerlund J. Ross Renew Guy Cammu Glenn S. Murphy Michiel Warlé Matias Vested Béla Fülesdi Reka Nemes Malachy O. Columb Daniela Damian Peter J. Davis Hajime Iwasaki Lars I. Eriksson 《Acta anaesthesiologica Scandinavica》2023,67(8):994-1017
The set of guidelines for good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents was developed following an international consensus conference in Copenhagen in 1996 (Viby-Mogensen et al., Acta Anaesthesiol Scand 1996, 40 , 59–74); the guidelines were later revised and updated following the second consensus conference in Stockholm in 2005 (Fuchs-Buder et al., Acta Anaesthesiol Scand 2007, 51 , 789–808). In view of new devices and further development of monitoring technologies that emerged since then, (e.g., electromyography, three-dimensional acceleromyography, kinemyography) as well as novel compounds (e.g., sugammadex) a review and update of these recommendations became necessary. The intent of these revised guidelines is to continue to help clinical researchers to conduct high-quality work and advance the field by enhancing the standards, consistency, and comparability of clinical studies. There is growing awareness of the importance of consensus-based reporting standards in clinical trials and observational studies. Such global initiatives are necessary in order to minimize heterogeneous and inadequate data reporting and to improve clarity and comparability between different studies and study cohorts. Variations in definitions of endpoints or outcome variables can introduce confusion and difficulties in interpretation of data, but more importantly, it may preclude building of an adequate body of evidence to achieve reliable conclusions and recommendations. Clinical research in neuromuscular pharmacology and physiology is no exception. 相似文献
7.
8.
J. M. Nolde M. P. Schlaich D. I. Sessler A. Mian T. B. Corcoran C. K. Chow M. T. V. Chan F. K. Borges M. H. McGillion P. S. Myles N. L. Mills P. J. Devereaux G. S. Hillis 《Anaesthesia》2023,78(7):853-860
Myocardial injury due to ischaemia within 30 days of non-cardiac surgery is prognostically relevant. We aimed to determine the discrimination, calibration, accuracy, sensitivity and specificity of single-layer and multiple-layer neural networks for myocardial injury and death within 30 postoperative days. We analysed data from 24,589 participants in the Vascular Events in Non-cardiac Surgery Patients Cohort Evaluation study. Validation was performed on a randomly selected subset of the study population. Discrimination for myocardial injury by single-layer vs. multiple-layer models generated areas (95%CI) under the receiver operating characteristic curve of: 0.70 (0.69–0.72) vs. 0.71 (0.70–0.73) with variables available before surgical referral, p < 0.001; 0.73 (0.72–0.75) vs. 0.75 (0.74–0.76) with additional variables available on admission, but before surgery, p < 0.001; and 0.76 (0.75–0.77) vs. 0.77 (0.76–0.78) with the addition of subsequent variables, p < 0.001. Discrimination for death by single-layer vs. multiple-layer models generated areas (95%CI) under the receiver operating characteristic curve of: 0.71 (0.66–0.76) vs. 0.74 (0.71–0.77) with variables available before surgical referral, p = 0.04; 0.78 (0.73–0.82) vs. 0.83 (0.79–0.86) with additional variables available on admission but before surgery, p = 0.01; and 0.87 (0.83–0.89) vs. 0.87 (0.85–0.90) with the addition of subsequent variables, p = 0.52. The accuracy of the multiple-layer model for myocardial injury and death with all variables was 70% and 89%, respectively. 相似文献
9.
M. Eikemo I. M. Meier G. E. Løseth M. Trøstheim N. Ørstavik E. N. Jensen E. L. Garland C. Berna G. Ernst S. Leknes 《Anaesthesia》2023,78(9):1102-1111
Exposure to opioid analgesics due to surgery increases the risk of new persistent opioid use. A mechanistic hypothesis for opioids' abuse liability rests on the belief that, in addition to pain relief, acute opioid treatment improves well-being (e.g. via euphoria) and relieves anxiety. However, opioids do not consistently improve mood in laboratory studies of healthy non-opioid users. This observational study determined how two commonly used opioid analgesics affected patients' subjective well-being in standard clinical practice. Day surgery patients rated how good and how anxious they felt before and after an open-label infusion of remifentanil (n = 159) or oxycodone (n = 110) in the operating theatre before general anaesthesia. One minute after drug injection, patients reported feeling intoxicated (> 6/10 points). Anxiety was reduced after opioids, but this anxiolytic effect was modest (remifentanil Cohen's d = 0.21; oxycodone d = 0.31). There was moderate to strong evidence against a concurrent improvement in well-being (Bayes factors > 6). After remifentanil, ratings of ‘feeling good’ were significantly reduced from pre-drug ratings (d = 0.28). After oxycodone, one in three participants felt better than pre-drug. Exploratory ordered logistic regressions revealed a link between previous opioid exposure and opioid effects on well-being, as only 14 of the 80 opioid-naïve patients reported feeling better after opioid injection. The odds of improved well-being ratings after opioids were higher in patients with previous opioid exposure and highest in patients with > 2 weeks previous opioid use (adjusted OR = 4.4). These data suggest that opioid-induced improvement of well-being is infrequent in opioid-naïve patients. We speculate that peri-operative exposure could increase risk of persistent use by rendering subsequent positive opioid effects on well-being more likely. 相似文献
10.
Chopard Romain Campia Umberto Morin Lucas Jering Karola S. Almarzooq Zaid I. Snyder Julia Elizabeth Rizzo Samantha Waxman Aaron B. Goldhaber Samuel Z. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(3):449-460
Journal of Thrombosis and Thrombolysis - Multidisciplinary pulmonary embolism (PE) response teams have garnered widespread adoption given the complexities of managing acute PE and provide a... 相似文献